Press Releases :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods.

Press Releases

CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025

Mar 20, 2025

CV Sciences Unveils New Aura Collection THC Fizz Tablets

Feb 5, 2025

CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs

Nov 21, 2024

CV Sciences, Inc. Reports Third Quarter 2024 Financial Results

Nov 14, 2024

CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024

Nov 8, 2024

CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements

Aug 27, 2024

CV Sciences, Inc. Reports Second Quarter 2024 Financial Results

Aug 13, 2024

CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024

Aug 7, 2024

CV Sciences, Inc. Reports First Quarter 2024 Financial Results

May 14, 2024

CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

May 13, 2024